ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

CRBU Caribou Biosciences Inc

1,62
-0,14 (-7,95%)
Zuletzt aktualisiert: 21:54:41
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Caribou Biosciences Inc CRBU NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,14 -7,95% 1,62 21:54:41
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,77 1,615 1,79 1,76
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.6.202422:03EDGAR2Form 8-K - Current report
03.6.202412:01EDGAR2Form 8-K - Current report
03.6.202401:00GLOBECaribou Biosciences Presents Encouraging Clinical Data from..
30.5.202422:01GLOBECaribou Biosciences to Host KOL Discussion with Webcast from..
07.5.202422:11EDGAR2Form 8-K - Current report
07.5.202422:05GLOBECaribou Biosciences Reports First Quarter 2024 Financial..
01.5.202422:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
24.4.202416:00GLOBECaribou Biosciences to Present Initial Dose Expansion Data..
15.4.202415:00GLOBECaribou Biosciences Announces Oral Presentation on In Vivo..
04.4.202422:00GLOBECaribou Biosciences Expands Clinical Development of CB-010..
11.3.202422:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
11.3.202421:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11.3.202421:22EDGAR2Form 8-K - Current report
11.3.202421:05GLOBECaribou Biosciences Reports Fourth Quarter and Full Year..
05.3.202422:30GLOBECaribou Biosciences to Present Preclinical Data on CB-012,..
22.2.202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
08.2.202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:18EDGAR2Form 3/A - Initial statement of beneficial ownership of..
09.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.1.202422:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08.1.202414:00EDGAR2Form 8-K - Current report
07.1.202417:00GLOBECaribou Biosciences Appoints Tim Kelly as Chief Technology..
22.12.202322:05EDGAR2Form 8-K - Current report
13.12.202312:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
13.12.202300:26DJNCaribou Biosciences Shares Rise 4.1% as FDA Approves..
12.12.202322:05EDGAR2Form 8-K - Current report
12.12.202322:02GLOBECaribou Biosciences Provides Regulatory Update on CB-010..
17.11.202322:06EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
17.11.202322:05EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
07.11.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:02EDGAR2Form 8-K - Current report
07.11.202322:00GLOBECaribou Biosciences Reports Third Quarter 2023 Financial..
06.11.202314:00GLOBECaribou Biosciences Announces Appointment of Sundar..
01.11.202321:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
18.10.202314:02EDGAR2Form 8-K - Current report
18.10.202314:00GLOBECaribou Biosciences Announces FDA Clearance of IND..
27.9.202314:00GLOBECaribou Biosciences Appoints Reigin Zawadzki as Chief People..
26.9.202322:05EDGAR2Form 8-K - Current report
29.8.202322:00GLOBECaribou Biosciences to Participate in Upcoming Investor..

Kürzlich von Ihnen besucht